WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$3.44
+0.16 (+4.88%)
Open$3.28
Previous Close$3.28
Day High$3.48
Day Low$3.27
52W High$4.48
52W Low$1.39
Volume—
Avg Volume171.6K
Market Cap206.46M
P/E Ratio—
EPS$-1.44
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+403.2% upside
Current
$3.44
$3.44
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.72M | 11.22M | 8.91M |
| Net Income | -25,126,119 | -29,096,123 | 2.41M |
| Profit Margin | -288.3% | -273.9% | 27.1% |
| EBITDA | -32,636,925 | -39,893,307 | 4.31M |
| Free Cash Flow | — | — | 1.46M |
| Rev Growth | -22.3% | -22.3% | +22.0% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |